behphar

What behphar does

Behphar Pharmaceutical Holding is a privately-held pharmaceutical group headquartered in Tehran, Iran, organized as a holding company over six wholly-owned subsidiaries that together cover the full pharmaceutical value chain. The subsidiaries operate in branded and generic manufacturing, importation and licensing of global pharma products, wholesale distribution, consumer health, plasma-derived biologics, and specialty therapeutics. The group serves Iran's healthcare market exclusively, supplying medicines and consumer health products to pharmacies, hospitals, healthcare providers, and end patients.

The group's manufacturing subsidiary operates GMP-certified facilities producing tablets, capsules, sterile vials, and other dosage forms, with annual capacity exceeding 350 million tablets/capsules, 20 million vials, and 400 million other dosage forms. Its distribution arm maintains 100% country coverage through 20+ distribution centers and a fleet of 160+ cold-chain vehicles compliant with GDP standards. The group's plasma collection infrastructure holds capacity for 200,000+ litres, supporting production of plasma-derived biological therapies. Compliance with GMP, GDP, and GSP standards is maintained across the platform, and the group operates a proprietary TRACE traceability system linking manufacturing, distribution, and dispensing nodes.

Behphar's business model integrates manufacturing, importation and licensing, wholesale distribution, and consumer marketing within a single corporate umbrella, capturing margin at multiple stages of the value chain rather than at a single link. Revenue is generated through B2B sales to pharmacies and healthcare institutions, consumer health product sales to end users, and licensing or distribution fees from global pharmaceutical manufacturers seeking an in-country partner in Iran. The group is privately held with no public revenue disclosure, and operations are confined to Iran, exposing the business to country-specific economic, regulatory, and geopolitical risk factors including currency volatility, sanctions, and pharmaceutical price controls.

Name

behphar

Legal name

Behphar Pharmaceutical Holding

Website

https://behphar.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

Behphar is a Tehran-based pharmaceutical holding company coordinating six wholly-owned subsidiaries across manufacturing, distribution, licensing and import, consumer health, plasma-derived biologics, and specialty therapeutics, serving Iran's healthcare market through pharmacies, hospitals, and patients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Drugs and Druggists' Sundries Merchant Wholesalers (42421), Medicinal and Botanical Manufacturing (325411)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Generic Finished Dosage Form (FDF) Manufacturing (HLAIABAH)

akta.pro secondary industries

Specialty Pharmaceutical Distributors (HLAIAJAB), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Drug Product Fill-Finish & Aseptic Manufacturing Services (HLAAAKAB)

Keywords

• Pharmaceutical manufacturing
• Cold-chain distribution
• Plasma-derived therapies
• Specialty therapeutics
• Consumer healthcare products

Headquarters

HQ city

Tehran

HQ country

Iran

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Manufacturing and Sales: Domestic manufacturing of finished pharmaceutical products (tablets, capsules, injectables, liquid and sterile dosage forms) sold to healthcare providers, pharmacies, and hospitals across Iran
2. Licensing and Importation: Market access services introducing high-value international therapies into Iran through licensing partnerships with global manufacturers, commercialization, and regulatory registration
3. National Distribution Services: Nationwide pharmaceutical distribution and logistics services through temperature-controlled network covering 100% of Iran
4. Consumer Healthcare Products: Sale of wellness, preventive care, OTC products, enzyme-based supplements, herbal medicines, skincare, and functional foods through Behestan Behdasht
5. Plasma-Derived Biologics: Collection and processing of plasma for life-saving therapies and biologic treatments

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Behphar Pharmaceutical Holding is an integrated pharmaceutical group operating across the full pharmaceutical value chain in Iran. The group conducts GMP-certified manufacturing of solid, liquid, and sterile dosage forms, licenses and imports finished international therapies, runs a nationwide temperature-controlled distribution and logistics network, collects plasma for biologic therapies, and sells consumer healthcare and specialty therapeutics (ophthalmic, orphan, and rare-disease treatments) through six wholly-owned subsidiaries.

Product overview

Behphar Pharmaceutical Holding operates as an integrated pharmaceutical ecosystem with a platform-plus-specialists architecture. The holding coordinates six specialized subsidiaries: Behestan Darou (market access and international licensing), Darousazi Behestan (GMP-certified domestic manufacturing), Behestan Pakhsh (nationwide distribution and logistics), Behestan Behdasht (consumer health and wellness), Behestan Plasma (plasma collection and biologics), and Valean Darou (specialty therapeutics in ophthalmology and rare diseases). Each subsidiary owns a defined segment of the pharmaceutical value chain, from manufacturing and importation through distribution and specialty care, unified under shared quality governance.

Differentiator

Problem solved

Functional benefit

Products and services

• Behestan Darou — Market Access and International Licensing Importation, licensing, commercialization, and regulatory registration of high-value international pharmaceutical therapies for the Iranian market; serves global manufacturers seeking Iran market entry.
• Darousazi Behestan — GMP-Certified Pharmaceutical Manufacturing Domestic GMP-certified manufacturing of finished pharmaceutical products (tablets, capsules, injectables, and other dosage forms) with technology transfer capability; serves hospitals, pharmacies, and healthcare institutions across Iran.
• Behestan Pakhsh — Nationwide Pharmaceutical Distribution and Logistics Nationwide pharmaceutical distribution with temperature-controlled cold-chain operations, 20+ regional distribution centers, 160+ vehicles, 20,000+ m² logistics space, and end-to-end traceability; serves pharmacies, hospitals, and healthcare institutions across Iran.
• Behestan Behdasht — Consumer Healthcare and Wellness Products Consumer health and wellness products including enzyme-based supplements, herbal medicines, skincare, and functional foods sold over-the-counter to end consumers for everyday health and preventive care.
• Behestan Plasma — Plasma Collection and Biologics Donor-centered plasma collection with hemovigilance protocols and 200,000+ litres annual capacity across major plasma centers in Iran; supports access to plasma-derived medicinal products for life-saving therapies.
• Valean Darou — Specialty Therapeutics Specialty therapeutics company providing ophthalmic, orphan, and rare-disease treatments, expanding access to advanced therapeutic care using biologic therapies.

Quantifiable outcome

• 100% country coverage through national logistics network
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Global Pharmaceutical ManufacturerscoreOEM/ Whitelabel/ Licensing PartnerBehestan Darou collaborates with global pharmaceutical manufacturers to introduce high-value therapies into Iran through licensing, partnership, and full regulatory registration. The company maintains global partnerships with international manufacturers for market access and commercialization of innovative products.

Scale indicators12 records

Recent moves13 records

Expansion highlights5 records

Broad incumbents

• McKesson: World's largest pharmaceutical distributor with extensive cold-chain and specialty distribution. Directly comparable to Behestan Pakhsh's nationwide, temperature-controlled distribution platform.
• Cardinal Health: Major U.S. pharmaceutical wholesale distributor with strong nuclear and specialty pharmacy distribution. Comparable to Behestan Pakhsh's nationwide pharma distribution model.
• Teva Pharmaceutical Industries: Global leader in generic finished dosage form manufacturing. Closely comparable to Darousazi Behestan across solid, liquid, and sterile generic manufacturing.

Direct peers

• Sobhan Oncology: Iranian oncology-focused pharmaceutical manufacturer. Comparable to Valean Darou's specialty/rare-disease therapeutics positioning and to the group's biologic therapy investments.
• CSL Behring: Leading manufacturer of plasma-derived and recombinant biologic therapies. Comparable to Behestan Plasma's plasma-derived medicinal products and Valean Darou's specialty biologics.
• Grifols: Global leader in plasma collection and plasma-derived therapies. Closely comparable to Behestan Plasma/Behestan Plasma Alborz's plasma collection and biologic therapy operations.
• Barakat Pharmaceutical Group: Iranian integrated pharmaceutical holding combining manufacturing, distribution, and biotech. Directly comparable as a vertically organized domestic pharma group serving the same market.
• Darou Pakhsh: Iran's largest pharmaceutical distribution and wholesaling group. Directly comparable to Behestan Pakhsh in pharma distribution and to Behphar's integrated manufacturing-distribution model in Iran.
• Tehran Darou Pharmaceutical: Major Iranian pharmaceutical manufacturer producing a broad portfolio of finished dosage forms. Closely comparable to Darousazi Behestan's GMP manufacturing operations and domestic generics focus.

Emerging players

• Cipla: Large emerging-market generic pharmaceutical manufacturer with broad dosage-form portfolio. Comparable to Darousazi Behestan in emerging-market generic manufacturing and access-focused strategy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/behphar

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about behphar